DC HIV Clinical Trials Unit
The District of Columbia Clinical Trials Unit (DC CTU)
['FUNDING_OTHER'] · GEORGE WASHINGTON UNIVERSITY · NIH-11237065
Runs HIV prevention and treatment clinical trials in Washington, D.C., enrolling people living with or at risk for HIV.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | GEORGE WASHINGTON UNIVERSITY (nih funded) |
| Locations | 1 site (WASHINGTON, UNITED STATES) |
| Trial ID | NIH-11237065 on ClinicalTrials.gov |
What this research studies
This program brings together two local clinics, Whitman-Walker Health and the George Washington University site, to run HIV treatment and prevention trials in D.C. The team follows strict safety, laboratory, pharmacy, data, and regulatory procedures while focusing on strong recruitment and retention of diverse participants. They will use community engagement and Good Participatory Practices to reach people both inside and outside clinic settings. Senior investigators will mentor newer researchers and work with local resources like the DC CFAR and DC Cohort to support trials.
Who could benefit from this research
Good fit: Adults in the Washington, D.C. area who are living with HIV or are at risk for HIV and who can attend visits at the Whitman-Walker or George Washington University clinical sites.
Not a fit: People who live far from D.C. or who do not meet the eligibility requirements for a specific trial will likely not receive direct benefit from participating.
Why it matters
Potential benefit: Could make HIV prevention and treatment options more accessible in Washington, D.C., and speed the testing of better therapies or prevention methods for people in the area.
How similar studies have performed: Existing HIV clinical trial networks have successfully tested many effective prevention and treatment approaches, and this CTU builds on that established model.
Where this research is happening
WASHINGTON, UNITED STATES
- GEORGE WASHINGTON UNIVERSITY — WASHINGTON, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: MAGNUS, MANYA — GEORGE WASHINGTON UNIVERSITY
- Study coordinator: MAGNUS, MANYA
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Acquired Immune Deficiency Syndrome Virus, Acquired Immunodeficiency Syndrome Virus